Market revenue in 2021 | USD 68.0 million |
Market revenue in 2028 | USD 125.7 million |
Growth rate | 9.2% (CAGR from 2021 to 2028) |
Largest segment | Buccal tablets/ lozenges |
Fastest growing segment | Sublingual Films And Wafers |
Historical data | 2016 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Sublingual Films And Wafers, Buccal Tablets/ Lozenges, Oral Sprays |
Key market players worldwide | Teva Pharmaceutical Industries Ltd, Pfizer Inc, Reckitt Benckiser Group PLC, Catalent Inc, Collegium Pharmaceutical Inc, Cynata Therapeutics Ltd, GlaxoSmithKline Consumer Healthcare (GSK CH India), Generex Biotechnology, ARx, Endo Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to buccal drug delivery systems market will help companies and investors design strategic landscapes.
Buccal tablets/ lozenges was the largest segment with a revenue share of 48.53% in 2021. Horizon Databook has segmented the Italy buccal drug delivery systems market based on sublingual films and wafers, buccal tablets/ lozenges, oral sprays covering the revenue growth of each sub-segment from 2016 to 2028.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy buccal drug delivery systems market , including forecasts for subscribers. This country databook contains high-level insights into Italy buccal drug delivery systems market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account